Cargando…

Stratification to predict the response to antioxidant

OBJECTIVE: To examine the effectiveness of stratification to identify and target antioxidant therapy for animal models of lethal sepsis and in patients who develop sustained hypotension. METHODS: Rats were subjected to sepsis induced by cecal ligation and puncture. Animals were divided into two grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritter, Cristiane, Constantino, Larissa, Michels, Monique, Gonçalves, Renata Casagrande, Fraga, Cassiana, Damásio, Danusa, Dal-Pizzol, Felipe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação de Medicina Intensiva Brasileira - AMIB 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206955/
https://www.ncbi.nlm.nih.gov/pubmed/32401970
http://dx.doi.org/10.5935/0103-507X.20200016
Descripción
Sumario:OBJECTIVE: To examine the effectiveness of stratification to identify and target antioxidant therapy for animal models of lethal sepsis and in patients who develop sustained hypotension. METHODS: Rats were subjected to sepsis induced by cecal ligation and puncture. Animals were divided into two groups: those with high and low plasma levels of interleukin-6. Following stratification, N-acetylcysteine plus deferoxamine or saline was administered to animals starting 3 and 12 hours after surgery. N-Acetylcysteine plus deferoxamine or placebo was administered within 12 hours of meeting the inclusion criteria in hypotensive patients. RESULTS: N-Acetylcysteine plus deferoxamine increased survival in the cecal ligation and puncture model when administered 3 and 12 hours after sepsis induction. When dividing animals that received antioxidants using plasma interleukin-6 levels, the protective effect was observed only in those animals with high IL-6 levels. The antioxidant effect of N-acetylcysteine + deferoxamine was similar in the two groups, but a significant decrease in plasma interleukin-6 levels was observed in the high-interleukin-6-level group. Compared with patients treated with antioxidants in the low-interleukin-6 subgroup, those in the high-interleukin-6 subgroup had a lower incidence of acute kidney injury but were not different in terms of acute kidney injury severity or intensive care unit mortality. CONCLUSION: Targeting antioxidant therapy to a high inflammatory phenotype would select a responsive population.